Moreover, it is known that HIF1α activity is also induced in non-hypoxic conditions by the hyperactivation of PI3K and RAS/RAF/ERK pathways, which is a direct consequence of genetic alterations that are common in thyroid cancer, such as PTEN deletion and RAS and BRAF mutations [154,155,156,157,158]. This evidence concerns the gene HIF1A and thyroid cancer.